258 related articles for article (PubMed ID: 29630893)
1. Regulation of VDAC1 contributes to the cardioprotective effects of penehyclidine hydrochloride during myocardial ischemia/reperfusion.
Lin D; Cui B; Ren J; Ma J
Exp Cell Res; 2018 Jun; 367(2):257-263. PubMed ID: 29630893
[TBL] [Abstract][Full Text] [Related]
2. Penehyclidine hydrochloride protects against anoxia/reoxygenation injury in cardiomyocytes through ATP-sensitive potassium channels, and the Akt/GSK-3β and Akt/mTOR signaling pathways.
Zi C; Zhang C; Yang Y; Ma J
Cell Biol Int; 2020 Jun; 44(6):1353-1362. PubMed ID: 32125033
[TBL] [Abstract][Full Text] [Related]
3. Penehyclidine hydrochloride regulates mitochondrial dynamics and apoptosis through p38MAPK and JNK signal pathways and provides cardioprotection in rats with myocardial ischemia-reperfusion injury.
Feng M; Wang L; Chang S; Yuan P
Eur J Pharm Sci; 2018 Aug; 121():243-250. PubMed ID: 29860115
[TBL] [Abstract][Full Text] [Related]
4. Penehyclidine hydrochloride preconditioning provides cardiac protection in a rat model of myocardial ischemia/reperfusion injury via the mechanism of mitochondrial dynamics mechanism.
Yang Y; Zhao L; Ma J
Eur J Pharmacol; 2017 Oct; 813():130-139. PubMed ID: 28755984
[TBL] [Abstract][Full Text] [Related]
5. Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia/reperfusion injury: involvement of VDAC1 downregulation.
Liao Z; Liu D; Tang L; Yin D; Yin S; Lai S; Yao J; He M
Mol Nutr Food Res; 2015 Mar; 59(3):454-64. PubMed ID: 25488258
[TBL] [Abstract][Full Text] [Related]
6. [The research on protective effect of penehyclidine hydrochloride in rats with myocardial ischemia/reperfusion injury].
Yanyan X; Duomao L; Zhaoqi W; Yanli Y; Yi C; Jun M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Dec; 27(12):955-8. PubMed ID: 27318336
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol protects cardiomyocytes against anoxia/reoxygenation via dephosphorylation of VDAC1 by Akt-GSK3 β pathway.
Tian M; Xie Y; Meng Y; Ma W; Tong Z; Yang X; Lai S; Zhou Y; He M; Liao Z
Eur J Pharmacol; 2019 Jan; 843():80-87. PubMed ID: 30445019
[TBL] [Abstract][Full Text] [Related]
8. Penehyclidine hydrochloride post-conditioning reduces ischemia/reperfusion-induced cardiomyocyte apoptosis in rats.
Tan H; Chen L; Ma J
Exp Ther Med; 2017 Nov; 14(5):4272-4278. PubMed ID: 29104640
[TBL] [Abstract][Full Text] [Related]
9. VDAC1 deacetylation is involved in the protective effects of resveratrol against mitochondria-mediated apoptosis in cardiomyocytes subjected to anoxia/reoxygenation injury.
Tong Z; Xie Y; He M; Ma W; Zhou Y; Lai S; Meng Y; Liao Z
Biomed Pharmacother; 2017 Nov; 95():77-83. PubMed ID: 28826100
[TBL] [Abstract][Full Text] [Related]
10. Penehyclidine hydrochloride prevents anoxia/reoxygenation injury and induces H9c2 cardiomyocyte apoptosis via a mitochondrial pathway.
Wang Z; Lin D; Zhang L; Liu W; Tan H; Ma J
Eur J Pharmacol; 2017 Feb; 797():115-123. PubMed ID: 28089921
[TBL] [Abstract][Full Text] [Related]
11. Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury.
Lin D; Ma J; Xue Y; Wang Z
PLoS One; 2015; 10(12):e0138051. PubMed ID: 26632817
[TBL] [Abstract][Full Text] [Related]
12. VDAC1 promotes cardiomyocyte autophagy in anoxia/reoxygenation injury via the PINK1/Parkin pathway.
Yang X; Zhou Y; Liang H; Meng Y; Liu H; Zhou Y; Huang C; An B; Mao H; Liao Z
Cell Biol Int; 2021 Jul; 45(7):1448-1458. PubMed ID: 33675282
[TBL] [Abstract][Full Text] [Related]
13. Postconditioning Protection Against Myocardiocyte Anoxia/Reoxygenation Injury From Penehyclidine Hydrochloride.
Ren JY; Lin DM; Wang CB; Yang YL; Wang ZQ; Cui BQ; Ma J
Drug Des Devel Ther; 2019; 13():3977-3988. PubMed ID: 32063699
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1.
Hu T; Zou HX; Le SY; Wang YR; Qiao YM; Yuan Y; Liu JC; Lai SQ; Huang H
Int J Mol Med; 2023 Nov; 52(5):. PubMed ID: 37800609
[TBL] [Abstract][Full Text] [Related]
15. MiR-7a-5p Attenuates Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis by Targeting VDAC1.
Lu H; Zhang J; Xuan F
Cardiovasc Toxicol; 2022 Feb; 22(2):108-117. PubMed ID: 34661851
[TBL] [Abstract][Full Text] [Related]
16. Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion.
Li D; Liu M; Tao TQ; Song DD; Liu XH; Shi DZ
Cell Physiol Biochem; 2014; 34(4):1413-26. PubMed ID: 25301366
[TBL] [Abstract][Full Text] [Related]
17. Ischemic preconditioning/ischemic postconditioning alleviates anoxia/reoxygenation injury via the Notch1/Hes1/VDAC1 axis.
Wang L; Lai S; Zou H; Zhou X; Wan Q; Luo Y; Wu Q; Wan L; Liu J; Huang H
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23199. PubMed ID: 35975741
[TBL] [Abstract][Full Text] [Related]
18. A New Aspect of Penehyclidine Hydrochloride in Alleviating Myocardial Ischemia-Reperfusion Injury: Ferroptosis.
Lin D; Cui B; Qi Z; Liu W; Zhang G
J Cardiovasc Transl Res; 2023 Dec; 16(6):1373-1382. PubMed ID: 37584895
[TBL] [Abstract][Full Text] [Related]
19. Sevoflurane preconditioning alleviates myocardial ischemia reperfusion injury through mitochondrial NAD
Qin X; Qin Q; Ran K; Yuan G; Chang Y; Wang Y; Xiao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1108-1119. PubMed ID: 36097779
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective time-window of Penehyclidine hydrochloride postconditioning: A rat study.
Tan H; Lin D; Wang Z; Yang Y; Ma J
Eur J Pharmacol; 2017 Oct; 812():48-56. PubMed ID: 28684235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
